Purchase channels and medication guide for the Lao version of the targeted drug ivonib/ivitinib

Ivosidenib/Ivosidenib, as an innovative targeted therapy, brings new hope to patients with acute myeloid leukemia (AML), locally advanced or metastatic cholangiocarcinoma, and relapsed or refractory myelodysplastic syndromes (MDS), especially those carrying IDH1 gene mutations. It helps restore normal cell functions by precisely inhibiting the activity of IDH1 enzyme, thereby effectively curbing the proliferation of tumor cells. Its unique targeting mechanism enables ivonib to demonstrate significant efficacy in the treatment of certain refractory diseases.

With the widespread use of drugs, in addition to original drugs, a number of generic drugs have emerged in the international market, including the generic version of ivonib launched by Lucius Pharmaceuticals in Laos. The ingredients of this drug are highly similar to the original drug. The common specification is 250mg*60 tablets. The price is close to the people, making it an affordable choice for many patients. It is understood that the market price of the Lao version of ivonib is about more than 6,000 yuan. Compared with the price of the domestic original drug, which is as high as about 70,000 yuan, it has significant advantages and has attracted much attention from patients.

Avosidenib is a prescription drug, and its treatment process must be conducted under the guidance of a doctor with extensive experience in cancer treatment. The drug comes in tablet form for easy oral administration. In the treatment of AML, it is usually used in combination with azacitidine and is taken once daily for 7 consecutive days at the beginning of each 28-day treatment cycle. Medication should be continued as long as the patient continues to obtain clinical benefit or tolerates treatment. For the treatment of biliary tract cancer, it needs to be taken once a day until the disease progresses or the patient cannot tolerate it.

Although the Lao version of ivonib has a price advantage, patients must consult a professional doctor before taking the drug to ensure that the drug meets the needs of their condition and fully understand the potential side effects and monitoring requirements. At the same time, regular medical examination and follow-up are also important links to ensure the effectiveness and safety of treatment.